Nephro-Urology Monthly

Published by: Kowsar

The Prevalence of HCV Infection in Hemodialysis Population and Compared ELISA and PCR Methods for Detecting of HCV Infection

Atieh Makhlough 1 , Mohammadreza Mahdavi 2 , Iradj Maleki 1 , Lotfollah Davoodi 3 , Tahoora Mousavi 4 , Seyed-Hosein Hasani-Mansoor 5 , Marjan Makhlough 6 and Mohammadreza Haghshenas 7 , *
Authors Information
1 Gut and liver research center, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, Iran
3 Infectious Disease Specialists, Antimicrobial Resistance Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
4 PhD Candidate in Molecular and Cell Biology, Molecular and Cell Biology Research Center, Student Research Committee, Mazandaran University of Medical Sciences, Sari, IR Iran
5 Research Committee Center, Faculty of Medical Sciences, Mazandaran University of Medical Sciences, Sari, Iran
6 Institute of Experimental Animal Research, Mazandaran University of Medical Sciences, Sari, Iran
7 Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Article information
  • Nephro-Urology Monthly: May 2017, 9 (3); e45144
  • Published Online: February 6, 2017
  • Article Type: Research Article
  • Received: January 3, 2017
  • Accepted: January 21, 2017
  • DOI: 10.5812/numonthly.45144

To Cite: Makhlough A, Mahdavi M, Maleki I, Davoodi L, Mousavi T, et al. The Prevalence of HCV Infection in Hemodialysis Population and Compared ELISA and PCR Methods for Detecting of HCV Infection, Nephro-Urol Mon. 2017 ; 9(3):e45144. doi: 10.5812/numonthly.45144.

Copyright © 2017, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Pfuntner A, Wier LM, Stocks C. Most frequent procedures performed in US hospitals, 2011. 2006;
  • 2. Rafiei A, Darzyani AM, Taheri S, Haghshenas MR, Hosseinian A, Makhlough A. Genetic diversity of HCV among various high risk populations (IDAs, thalassemia, hemophilia, HD patients) in Iran. Asian Pac J Trop Med. 2013; 6(7): 556-60[DOI][PubMed]
  • 3. Boelaert JR, Daneels RF, Schurgers ML, Matthys EG, Gordts BZ, Van Landuyt HW. Iron overload in haemodialysis patients increases the risk of bacteraemia: a prospective study. Nephrol Dial Transplant. 1990; 5(2): 130-4[PubMed]
  • 4. Ibrahim IM. TTV As A Risk Factor In Hemodialysis Process. 2010;
  • 5. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003; 63(3): 793-808[DOI][PubMed]
  • 6. Loghman-Adham M. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care. 2003; 9(2): 155-71[PubMed]
  • 7. Rafiei AR, Hosseinikhah Z, Haghshenas MR, Taheri S, Darziani M. Determination hcv genotype in high risk group (hemophilia-talasemic-dialysis-iv drug user) in mazandaran province in sari city. 2012;
  • 8. Rafiei AR, Haghshenas MR, Darzyani Azizi M, Taheri S, Babamahmoudi F, Makhlough A, et al. Risk Factors for Hepatitis C Virus Among High-Risk Populations (Intravenous Drug Addicts and Patients with Thalassemia, Hemophilia, Hemodialysis) in Mazandaran. J Mazandaran Univ Med Sci. 2011; 21(81): 32-42
  • 9. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67[DOI][PubMed]
  • 10. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002; 36(1): 3-10[DOI][PubMed]
  • 11. Handajani R, Lusida MI, Darmadi S, Adi P, et al. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. J Clin Microbiol. 1996; 34(12): 2875-80[PubMed]
  • 12. Reviews: Hepatitis C Virus Infection and the Dialysis Patient. Seminars in dialysis. : 416-22
  • 13. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2): 41-6[PubMed]
  • 14. Makhlough A, Mohdavi M, Roshan P. Epidemiology and Treatment of Hepatitis C infection in Hemodialysis patients. J Clin Excellence. 2013; 1(1): 26-43
  • 15. Mahdavi-Mazdeh M, Zamyadi M, Nafar M. Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran. Nephrol Dial Transplant. 2008; 23(1): 288-93[DOI][PubMed]
  • 16. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, et al. Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol. 2007; 18(5): 1584-93[DOI][PubMed]
  • 17. Allander T, Medin C, Jacobson SH, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol. 1994; 43(4): 415-9[PubMed]
  • 18. Thompson ND, Novak RT, Datta D, Cotter S, Arduino MJ, Patel PR, et al. Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol. 2009; 30(9): 900-3[DOI][PubMed]
  • 19. Intramuscular I. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. 1998;
  • 20. De Crignis E, Re MC, Cimatti L, Zecchi L, Gibellini D. HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR. J Virol Methods. 2010; 165(1): 51-6[DOI][PubMed]
  • 21. Fuentes M, Mateo C, Rodriguez A, Casqueiro M, Tercero JC, Riese HH, et al. Detecting minimal traces of DNA using DNA covalently attached to superparamagnetic nanoparticles and direct PCR-ELISA. Biosens Bioelectron. 2006; 21(8): 1574-80[DOI][PubMed]
  • 22. Makhlough A, Jamshidi M, Mahdavi MR. Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran. Singapore Med J. 2008; 49(11): 921-3[PubMed]
  • 23. Makhloogh A, Mahdavi MR, Haghshenas M, Ghasemian R, Jamshidi M. Hepatitis C prevalence in hemodialysis patients in Mazandaran, Iran: A survey by polymerase chain reaction and serological methods. Res J Biol Sci. 2008; 3(4): 265-8
  • 24. Barrera JM, Francis B, Ercilla G, Nelles M, Achord D, Darner J, et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang. 1995; 68(1): 15-8[PubMed]
  • 25. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011; 17(2): 107-15[DOI][PubMed]
  • 26. Gretch DR. Diagnostic tests for hepatitis C. Hepatology. 1997; 26(3 Suppl 1): 43S-7S[DOI][PubMed]
  • 27. von Lode P. Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clin Biochem. 2005; 38(7): 591-606[DOI][PubMed]
  • 28. Myers FB, Lee LP. Innovations in optical microfluidic technologies for point-of-care diagnostics. Lab Chip. 2008; 8(12): 2015-31[DOI][PubMed]
  • 29. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007; 71(5): 438-41[DOI][PubMed]
  • 30. Erensoy S. Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy. J Clin Virol. 2001; 21(3): 271-81[PubMed]
  • 31. Krajden M. Hepatitis C virus diagnosis and testing. Can J Public Health. 2000; 91 Suppl 1-9[PubMed]
  • 32. Khudyakov YE, Obriadina A. Compositions and methods for simultaneous detection of hcv antigen/antibody. 2014;
  • 33. Odari EO. Evaluation of a “combination” ELISA kit and genotyping performance of Restriction Fragment Length Polymorphism among Hepatitis C Virus infected patients’ sera. 2016;
  • 34. Maraqa A, Amr SS, Abdalhamid B. HCV Core Antigen Testing versus HCV PCR Testing for Early Detection of HCV Infection. Egypt J Med Microbiol. 2014; 23(2)
  • 35. Alter MJ, Kuhnert WL, Finelli L, Centers for Disease C. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003; 52: 1-13[PubMed]
  • 36. Moini M, Ziyaeyan M, Aghaei S, Sagheb MM, Taghavi SA, Moeini M, et al. Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction. Hepat Mon. 2013; 13(6)[DOI][PubMed]
  • 37. Caramelo C, Bartolome J, Albalate M, de Sequera P, Navas S, Bermejillo T, et al. Undiagnosed hepatitis C virus infection in hemodialysis patients: value of HCV RNA and liver enzyme levels. Kidney Int. 1996; 50(6): 2027-31[PubMed]
  • 38. Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, et al. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant. 2004; 19(4): 904-9[DOI][PubMed]
  • 39. Duong CM, Olszyna DP, McLaws ML. Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study. BMC Public Health. 2015; 15: 192[DOI][PubMed]
  • 40. Tu AW, Buxton JA, Whitlock M, Djurdjev O, Chong M, Krajden M, et al. Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol. 2009; 20(2)-23[PubMed]
  • 41. Decker CF. Emerging sexually transmitted diseases: Hepatitis C, lymphogranuloma venereum (LGV), and Mycoplasma genitalium infections. Dis Mon. 2016; 62(8): 314-8[DOI][PubMed]
  • 42. Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, et al. Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort. J Viral Hepat. 2015; 22(12): 1020-32[DOI][PubMed]
  • 43. Fedele R, Salooja N, Martino M. Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation. Expert Opin Biol Ther. 2016; 16(11): 1361-72[DOI][PubMed]
  • 44. Wedemeyer H, Dore GJ, Ward JW. Estimates on HCV disease burden worldwide - filling the gaps. J Viral Hepat. 2015; 22 Suppl 1: 1-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments